advertisement

Topcon

Toro MD 13

Showing records 1 to 13 | Display all abstracts from Toro MD

89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Posarelli C
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Fiedorowicz M; Wełniak-Kamińska M
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Toro MD; Rejdak R
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Świątkiewicz M
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Żarnowski T
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Orzeł J; Chorągiewicz T
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Pożarowska D
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Toro MD
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Longo A; Miccoli M
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Rejdak R; Bogorodzki P
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Nardi M
Journal of clinical medicine 2020; 9:
90586 Changes of Ocular Dimensions as a Marker of Disease Progression in a Murine Model of Pigmentary Glaucoma
Grieb P
Frontiers in pharmacology 2020; 11: 573238
89973 Safety and Efficacy of Second Ahmed Valve Implant in Refractory Glaucoma
Figus M
Journal of clinical medicine 2020; 9:

Issue 21-3

Change Issue


advertisement

Topcon